Inactive Instrument

Appliance Recycling Cntrs of Amer Inc Stock Nasdaq

Equities

US03814F2056

Biotechnology & Medical Research

Sales 2022 39.61M Sales 2023 - Capitalization 2.75M
Net income 2022 11M Net income 2023 -7M EV / Sales 2022 0.41 x
Net Debt 2022 12.02M Net Debt 2023 416K EV / Sales 2023 -
P/E ratio 2022
0.39 x
P/E ratio 2023
-0.28 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 98.74%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 71 15-04-30
Director of Finance/CFO 64 17-08-20
Chief Tech/Sci/R&D Officer - 20-01-28
Members of the board TitleAgeSince
Chief Executive Officer 71 15-04-30
Director/Board Member 74 15-04-30
Director/Board Member 40 18-07-31
More insiders
JanOne Inc. is a clinical-stage pharmaceutical company. The Company is focused on identifying, acquiring, licensing, developing, partnering, and commercializing non-opioid and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. Its drug candidate, JAN101, is an oral pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities, such as those with vascular complications of diabetes or Peripheral Artery Disease (PAD) and treats pain. It operates in two segments: Biotechnology and Technology. Its biotechnology segment is focused on finding treatments for conditions that cause severe pain and to market drugs with non-addictive pain-relieving properties. Its recycling segment is an appliance recycling program, which offers recycling, replacement and additional services for utility energy efficiency programs and have established 20 Regional Processing Centers (RPCs) throughout the United States and Canada.
More about the company